Get all your news in one place.
100's of premium titles.
One app.
Start reading
Dublin Live
Dublin Live
Health
Tim Hanlon & Alex Dunne

Experimental cancer drug 'cures almost every patient' in exciting trial

Doctors have been left astonished after an experimental cancer drug caused every patient in a trial to enter remission.

The drug dostarlimab appeared to cure every patient during a clinical trial at the Memorial Sloan Kettering Cancer Center (MSKCC) in New York.

The cancer drug was given to 18 people with a type of rectal cancer every three weeks for six months.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.